LC

Laia Crespo

Partner - Sanofi Ventures

Paris, Île-de-France

Invests in

Stages:

Sectors:

Boston / New England

Locations:

Cambridge, Massachusetts

Min Investment:
$5,000,000.00
Max Investment:
$10,000,000.00
Target Investment:
$7,500,000.00

Education

MBA
University of Cambridge
First Degree, MSc and PhD
Universitat de Barcelona
Bachelors Degree
Liceu Music Conservatoire

Investments

Eligo Bioscience

Total Funding: $48M

QurAlis

Total Funding: $140M

OMass Therapeutics

Total Funding: $95M

Lava Therapeutics

Total Funding: $100M

Inbiomotion

Total Funding: $4M

Minoryx Therapeutics

Total Funding: $81M

AM Pharma

Total Funding: $210M

Work Experience

2018

Partner - Sanofi Ventures
2018
Current board member in Eligo Bioscience, Muna Therapeutics, NodThera, OMass Therapeutics, QurAlis, T-Therapeutics and Therini Bio. Previous investor / board member in Lava Therapeutics (LVTX)

2009 - 2018

Investment Director
2015 - 2018
Board Member in Minoryx, OxThera
Investment Manager
2009 - 2015
Board member in AM-Pharma, Inbiomotion

Johnson & Johnson

2008 - 2009

New Business Development Analyst for Europe, Middle East and Africa
2008 - 2009

2007 - 2007

Research Scientist
2007 - 2007

2004 - 2007

Research Scientist
2004 - 2007

Spirogen (now AstraZeneca)

2002 - 2003

Research Scientist
2002 - 2003